Cellebrite DI Ltd. announced that Haim Shani has retired as a director of the Company, effective immediately. Mr. Shani had been a distinguished member of the Board since 2019, including two years as Chairman from August 2021 until August 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.63 USD | -1.67% | 0.00% | +23.67% |
Apr. 19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
Apr. 01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.67% | 2.22B | |
+4.93% | 2,894B | |
+1.16% | 80.94B | |
+0.66% | 75.01B | |
-16.29% | 52.08B | |
+27.20% | 48.93B | |
-28.11% | 44.85B | |
+17.09% | 40.49B | |
+52.96% | 36.29B | |
-11.35% | 24.36B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite Di Ltd Announces Retainment of Haim Shani as Director